Clarity with
Crown

Recognize your next clinical candidate when you see it.

Our Translational Platforms enable our clients to identify the right patients for the right treatment. Having models which more accurately mimic human disease and population dynamics are key to successfully translating promising compounds into successful clinical candidates, whether treating Oncology or Diabetes related diseases.

Join us at AACR

April 2-5, 2017 - Washington, DC

Come see us at Booth # 1847 to discuss one of our 14 posters. Or, schedule a scientific consultation on your next study design.

Magnify your
insights

Understand the mechanisms of disease.

Our scientific acumen and experience will give you a deeper understanding of not just the pharmacological profile of your compound, but more importantly, a clear understanding of which compounds to progress into the clinic. Take a look at our publications to get a deeper understanding of the depth of our scientific expertise.

Begin with the
end insight

Connecting science to patients.

We help our clients solve some of today's most pressing problems in oncology, cardiovascular, and metabolic disease by answering some of the most challenging questions about human biology.

CVMD

Models of Obesity

obesity-img.jpg

CrownBio’s preclinical Translational Technology Platforms provide spontaneous & diet-induced obesity (DIO) models, to support the transition of new agents into the clinic.

Learn More

Oncology

Oncology Databases

databases-img.jpg

Our unique databases provide a curated source of well-characterized models available to use for drug discovery including PDX models, cell lines, and syngeneic models.

Learn More

CVMD

Diabetes Models

oncoexpress-img.jpg

Models of both Type 1 and Type 2 diabetes, including conventional, as well as unique, highly translatable models for in vivo efficacy studies of antidiabetic agents.

Learn More

Latest from our Blog

December 13, 2016

Targeting Cardio-Metabolic Disease Symposium

Highlights from the NASH symposium and panel discussion in Boston, MA (Sep 20-21, 2016) Amar Thyagarajan, PhD

Read More

December 13, 2016

Targeting Cardio-Metabolic Disease Symposium

Highlights from the NASH symposium and panel discussion in Boston, MA (Sep 20-21, 2016) Amar...

Read More

October 6, 2016

Breast Cancer No Longer Scary as we Reveal Its Smarter Disguises

October is breast cancer awareness month and CrownBio has reviewed the latest breast cancer...

Read More

September 27, 2016

All You Need to Know About Non-Alcoholic Fatty Liver Disease

Non-Alcoholic Fatty liver disease (NAFLD) is a complex condition where an excessive amount of...

Read More

September 13, 2016

Obesity Linked To Self-Eating Beige Fat

Humans, like all mammals, have two types of fat with completely opposite functions: white, which...

Read More

September 6, 2016

All About Leukemia for Childhood Cancer Month

September is Childhood Cancer Awareness Month, raising awareness and providing time for...

Read More

Upcoming Events


March 20 - 22, 2017

4th Immunotherapy of Cancer Conference

Prague, Czech Republic - Booth #13

http://itoc-conference.eu/itoc4


April 1 - 5, 2017

AACR 2017 Annual Meeting

Washington DC, MA - Booth  #1847

www.aacr.org


May 5, 2017

Crown Bioscience Symposium

Boston, MA


June 2 - 6, 2017

ASCO 2017 Annual Meeting

Booth #17017

https://am.asco.org/


June 21, 2017

Crown Bioscience Symposium 2017

Paris, France